IP Library Assignment 055765/0953
Patent Assignment
Reel/Frame 055765/0953

Assignment of Assignor's Interest

Recorded: 2021-03-30 Pages: 18
Assignor
OPKO IRELAND GLOBAL HOLDINGS, LTD.
Executed: 2021-03-24
Assignee
EIRGEN PHARMA LTD.
WESTSIDE BUSINESS PARK, OLD KILMEADEN ROAD, WATERFORD, X91 YV67, IRELAND
Covered Properties (57)
Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof
Application: 60/530,604 →
Process For Producing Phosphineoxide Vitamin D Precursors
Application: 60/940,866 →
Methods and Compositions for Controlled Release Oral Dosage of a Vitamin D Compound
Application: 60/913,853 →
Methods for Controlled Release Oral Dosage of a Vitamin D Compound
Application: 15/726,046 →
Publication: US 2018/0028453
Method of treating and preventing secondary hyperparathyroidism
Application: 60/815,148 →
Method of Treating and Preventing Secondary Hyperparathyroidism
Application: 16/858,395 →
Publication: US 2020/0253987
Methods of Diagnosing Vitamin D Deficiency, Susceptibility Thereto, Treatment Thereof, and Prevention Thereof
Application: 61/041,898 →
Methods of Diagnosing Vitamin D Deficiency, Susceptibility Thereto, Treatment Thereof, and Prevention Thereof
Application: 61/161,292 →
Stabilized 1,25-Dihydroxyvitamin D2 and Method of Making Same
Application: 61/036,021 →
Stabilized 1,25-Dihydroxyvitamin D2 and Method of Making Same
Application: 12/403,271 →
Publication: US 2009/0233889
Stabilized 1, 25-Dihydroxyvitamin D2 and Method of Making Same
Application: 14/146,397 →
Publication: US 2014/0113886
Methods and Compositions for administration of a vitamin D compound
Application: 61/318,741 →
Methods and Compositions for Controlled Release Oral Dosage of a 25-Hydroxyvitamin D Compound
Application: 61/405,196 →
Methods and Compositions for Reducing Parathyroid Levels
Application: 13/638,845 →
Publication: US 2013/0137663
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
Application: 61/801,896 →
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
Application: 16/448,838 →
Publication: US 2019/0374555
Adjunctive Therapy With 25-Hydroxyvitamin D
Application: 15/502,498 →
Publication: US 2018/0085381
Adjunctive Therapy with 25-Hydroxyvitamin D
Application: 16/726,225 →
Adjunctive Therapy with 25-Hydroxyvitamin D
Application: 16/859,865 →
Publication: US 2020/0253988
Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor
Application: 15/720,764 →
Publication: US 2018/0021354
Adjunctive Therapy with 25-Hydroxyvitamin D and Articles Therefor
Application: 16/700,329 →
Publication: US 2020/0101089
Methods of Treating Vitamin D Insufficiency in Chronic Kidney Disease
Application: 16/089,235 →
Publication: US 2019/0083513
Use of Calcifediol In Bariatric Surgery Patients
Application: 62/652,038 →
Use of Calcifediol in Bariatric Surgery Patients
Application: 16/374,348 →
Publication: US 2019/0298744
Pediatric Dosage Forms, Methods of Making and Using
Application: 16/869,273 →
Publication: US 2020/0338006
Activating Endogenous Antimicrobials To Treat SARS-COV-2 Infection
Application: 63/006,034 →
Activating Endogenous Antimicrobials To Treat SARS-CoV-2 Infection
Application: 63/006,563 →
Activating Endogenous Antimicrobials to Treat Sars-Cov-2 Infection
Application: 63/009,155 →
Activating Endogenous Antimicrobials To Treat SARS-COV-2 Infection
Application: 63/012,781 →
Activating Endogenous Antimicrobials to Treat Sars-Cov-2 Infection
Application: 63/032,714 →
Stable Cytochrome P450 24 (CYP24) Expressing Cell Line and Methods and Uses Thereof
Patent: 7,288,407 →
Application: 10/513,302 →
Publication: US 2006/0105417
Cytochrome P450 24 (CYP24) Monoclonal Antibody and Methods and Uses Thereof
Patent: 7,427,670 →
Application: 11/013,435 →
Publication: US 2005/0208055
Process for Producing Phosphine Oxide Vitamin D Precursors
Patent: 8,039,676 →
Application: 12/128,992 →
Publication: US 2008/0300427
Methods and Compositions for Controlled Release Oral Dosage of a Vitamin D Compound
Patent: 8,361,488 →
Application: 12/109,983 →
Publication: US 2009/0176748
Method for Treating Secondary Hyperparathyroidism in Ckd
Patent: 8,207,149 →
Application: 13/244,945 →
Publication: US 2012/0015916
Methods for Controlled Release Oral Dosage of a Vitamin D Compound
Patent: 8,778,373 →
Application: 13/746,982 →
Publication: US 2013/0131022
Methods for Controlled Release Oral Dosage of a Vitamin D Compound
Patent: 9,918,940 →
Application: 14/305,863 →
Publication: US 2014/0357603
Method for Treating Secondary Hyperparathyroidism in CKD
Patent: 9,408,858 →
Application: 14/690,131 →
Publication: US 2015/0216881
Method for Controlled Release Oral Dosage of a Vitamin D Compound
Patent: 9,498,486 →
Application: 15/231,357 →
Publication: US 2016/0346299
Method for Treating Secondary Hyperparathyroidism in Ckd
Patent: 9,925,147 →
Application: 15/358,065 →
Publication: US 2017/0119677
Method of Treating and Preventing Secondary Hyperparathyroidism
Patent: 8,329,677 →
Application: 12/305,572 →
Publication: US 2009/0209501
Method of Treating and Preventing Secondary Hyperparathyroidism
Patent: 9,402,855 →
Application: 13/680,997 →
Publication: US 2013/0178451
Method of Treating and Preventing Secondary Hyperparathyroidism
Patent: 9,913,852 →
Application: 15/220,963 →
Publication: US 2016/0331765
Method of Treating and Preventing Secondary Hyperparathyroidism
Application: 15/918,620 →
Publication: US 2018/0296576
Methods Useful for Vitamin D Deficiency and Related Disorders
Patent: 8,962,239 →
Application: 12/935,139 →
Publication: US 2011/0052567
Methods Useful for Vitamin D Deficiency and Related Disorders
Patent: 9,500,661 →
Application: 14/607,725 →
Publication: US 2015/0141385
Methods Useful for Vitamin D Deficiency and Related Disorders
Application: 15/357,059 →
Publication: US 2017/0067917
Methods and Composition for Measuring the Amount of Vitamin D Derivatives
Patent: 8,574,862 →
Application: 13/318,442 →
Publication: US 2012/0094396
Methods and Composition for Measuring the Amount of Vitamin D Derivatives
Patent: 9,382,307 →
Application: 14/049,692 →
Publication: US 2014/0039157
Phosphate Management with Small Molecules
Patent: 9,198,923 →
Application: 13/146,217 →
Publication: US 2012/0028926
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
Patent: 9,861,644 →
Application: 14/213,285 →
Publication: US 2014/0349979
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
Application: 15/720,948 →
Publication: US 2018/0117068
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
Application: 15/990,352 →
Publication: US 2018/0271884
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
Application: 15/990,354 →
Publication: US 2018/0271885
Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor
Application: 14/866,155 →
Publication: US 2016/0038514
Adjunctive Therapy with 25-Hydroxyvitamin D and Articles Therefor
Application: 16/243,549 →
Publication: US 2019/0142847
Method of Treating Vitamin D Insufficiency and Deficiency
Application: 12/597,230 →
Publication: US 2010/0120728
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 19, 2006
From: BISHOP, CHARLES W; CRAWFORD, KEITH H; MESSNER, ERIC J
To: PROVENTIV THERAPEUTICS, LLC
Reel/Frame 017959/0789 →
Assignment of Assignor's Interest Jun 1, 2007
From: SAHA, UTTAM
To: CYTOCHROMA INC.
Reel/Frame 019418/0279 →
Assignment of Assignor's Interest Jun 14, 2007
From: BISHOP, CHARLES W.
To: PROVENTIV THERAPEUTICS, LLC.
Reel/Frame 019461/0547 →
Assignment of Assignor's Interest Jun 14, 2007
From: TABASH, SAMIR; WHITE, JAY A.
To: CYTOCHROMA INC.
Reel/Frame 019461/0668 →
Assignment of Assignor's Interest Apr 9, 2008
From: SAHA, UTTAM
To: CYTOCHROMA INC.
Reel/Frame 020776/0249 →
Assignment of Assignor's Interest Jun 2, 2008
From: PETKOVICH, P. MARTIN; HELVIG, CHRISTIAN F.
To: CYTOCHROMA INC.
Reel/Frame 021026/0781 →
Assignment of Assignor's Interest Aug 6, 2008
From: MELNICK, JOEL Z.
To: PROVENTIV THERAPEUTICS, LLC.
Reel/Frame 021349/0257 →
Assignment of Assignor's Interest Mar 26, 2009
From: SAHA, UTTAM
To: CYTOCHROMA INC.
Reel/Frame 022454/0677 →
Assignment of Assignor's Interest Apr 6, 2009
From: PETKOVICH, P. MARTIN; HELVIG, CHRISTIAN F.
To: CYTOCHROMA INC.
Reel/Frame 022508/0315 →
Assignment of Assignor's Interest Apr 16, 2010
From: TABASH, SAMIR P.; WHITE, JAY A.; AGUDOAWU, SAMMY ASIAMAH
To: CYTOCHROMA INC.
Reel/Frame 024247/0569 →
Assignment of Assignor's Interest Apr 16, 2010
From: BISHOP, CHARLES W.
To: PROVENTIV THERAPEUTICS, LLC.
Reel/Frame 024247/0556 →
Assignment of Assignor's Interest Sep 7, 2010
From: MELNICK, JOEL Z.
To: PROVENTIV THERAPEUTICS, LLC
Reel/Frame 024945/0870 →
Security Agreement Sep 28, 2010
From: CYTOCHROMA INC.; PROVENTIV THERAPEUTICS, LLC; CYTOCHROMA HOLDINGS ULC
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 025051/0215 →
Assignment of Assignor's Interest Jan 11, 2011
From: BISHOP, CHARLES W.; MELNICK, JOEL Z.
To: CYTOCHROMA INC.
Reel/Frame 025616/0663 →
Security Agreement Aug 16, 2012
From: CYTOCHROMA INC., A CORPORATION EXISTING UNDER THE LAWS OF ONTARIO
To: COMERICA BANK, A TEXAS BANKING ASSOCIATION AND AUTHORIZED FOREIGN BANK UNDER THE BANK ACT (CANADA)
Reel/Frame 028801/0539 →
Release of Security Interest Aug 31, 2012
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: CYTOCHROMA, INC.; CYTOCHROMA HOLDINGS ULC; PROVENTIV THERAPEUTICS, LLC
Reel/Frame 028881/0338 →
Release of Security Interest Mar 4, 2013
From: COMERICA BANK, A TEXAS BANKING ASSOCIATION AND AUTHORIZED FOREIGN BANK UNDER THE BANK ACT (CANADA)
To: CYTOCHROMA INC.
Reel/Frame 029914/0404 →
Assignment of Assignor's Interest Mar 14, 2013
From: PETKOVICH, P. MARTIN; WHITE, JAY A.; TABASH, SAMIR P.; MELNICK, JOEL Z.
To: CYTOCHROMA INC.
Reel/Frame 029999/0531 →
Assignment of Assignor's Interest Mar 14, 2013
From: MESSNER, ERIC J.; BISHOP, CHARLES W.
To: PROVENTIV THERAPEUTICS, LLC
Reel/Frame 029999/0628 →
Assignment of Assignor's Interest Nov 4, 2013
From: WHITE, JAY A.; TABASH, SAMIR P.; AGUDOAWU, SAMMY A.; MELNICK, JOEL Z
To: OPKO IP HOLDINGS II, INC.
Reel/Frame 031539/0977 →
Nunc Pro Tunc Assignment Jul 31, 2015
From: CYTOCHROMA CAYMAN ISLANDS LTD.
To: OPKO IP HOLDINGS II, INC.
Reel/Frame 036224/0163 →
Nunc Pro Tunc Assignment Jul 31, 2015
From: OPKO HEALTH, INC.
To: OPKO RENAL, LLC
Reel/Frame 036243/0691 →
Assignment of Assignor's Interest Jul 31, 2015
From: PROVENTIV THERAPEUTICS, LLC
To: OPKO HEALTH, INC.
Reel/Frame 036225/0082 →
Nunc Pro Tunc Assignment Jul 31, 2015
From: CYTOCHROMA INC.
To: CYTOCHROMA CAYMAN ISLANDS LTD.
Reel/Frame 036238/0359 →
Confirmatory Patent Rights Agreement Jul 31, 2015
From: OPKO IP HOLDINGS II, INC.
To: OPKO IRELAND GLOBAL HOLDINGS, LTD.
Reel/Frame 036238/0486 →